Form4insider filings, from the source

SEC Form 4 · accession 0001179110-16-020575

AMAG PHARMACEUTICALS INC. · AMAG

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Frank E Thomas
Officer — President & COO
Period of report
Feb 26, 2016
Accepted (ET)
Mar 1, 2016 · 5:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 26, 2016F7,417$27.01D99,529D
Common StockF2Feb 26, 2016F1,361$27.01D98,168D
Common StockF3Feb 27, 2016F458$27.01D97,710D
Common StockF4Feb 29, 2016F515$26.28D97,195D
Common StockF5,F6,F8Mar 1, 2016A17,000—A114,195D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F8,F7$25.18Mar 1, 2016A40,000A—Mar 1, 2026Common Stock40,00040,000D

Explanation of responses